Home > Quotes > OPK > Press Releases

Opko Health Inc Press Releases

OPK 
$7.14
*  
0.07
  negative  
0.99%
Get OPK Alerts
*Delayed - data as of Jun. 18, 2013 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

PROLOR Biotech Initiates Pivotal Phase III Trial Of Its Longer-Acting Version Of Human Growth Hormone
06/04/2013 7:30AM - PR Newswire

OPKO Health to Present at the Jefferies 2013 Global Healthcare Conference
05/30/2013 9:32AM - Business Wire

OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules)
05/23/2013 9:32AM - Business Wire

OPKO Announces First Quarter 2013 Operating and Financial Highlights
05/09/2013 1:10PM - Business Wire

Rigrodsky & Long, P.A. Announces Investigation Of PROLOR Biotech, Inc. Buyout
04/25/2013 9:35PM - Business Wire

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of PROLOR Biotech, Inc. Shareholders
04/25/2013 1:09PM - Business Wire

Ryan & Maniskas, LLP Announces Investigation of PROLOR Biotech, Inc.
04/25/2013 10:56AM - PR Newswire

PROLOR Biotech Investor Alert by Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates PROLOR Biotech, Inc. Following Announcement of Acquisition by OPKO Health, Inc. for Potential Conflicts and Self Dealing
04/24/2013 9:17PM - Business Wire

Acquisition of PROLOR Biotech, Inc. by OPKO Health, Inc. May Not Be in the Best Interests of PROLOR Shareholders
04/24/2013 8:11PM - PR Newswire

Rigrodsky & Long, P.A. Announces Investigation Of PROLOR Biotech, Inc. Buyout
04/24/2013 7:15PM - Business Wire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of PROLOR Biotech, Inc. - PBTH
04/24/2013 3:50PM - PR Newswire

Management Buyout Of PROLOR - Law Firm Seeks Higher Price For Shareholders
04/24/2013 10:03AM - PR Newswire

OPKO Health To Acquire PROLOR Biotech
04/24/2013 2:00AM - PR Newswire

OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company
04/18/2013 9:43AM - Business Wire

OPKO Health Announces Publication of Study Detecting Antibodies in NMO Patients Using OPKO Screening Technology
04/05/2013 11:45AM - Business Wire